Celldex Therapeutics shares owned by Guggenheim Capital, LLC Managers
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Guggenheim Capital, LLC Managers
from 13F filings
Historical chart of Guggenheim Capital, LLC Managers investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Guggenheim Capital, LLC Managers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Guggenheim Capital, LLC Managers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $588k | 23k | 25.87 |
| 2025-06-30 | $529k | 26k | 20.35 |
| 2025-03-31 | $450k | 25k | 18.15 |
| 2024-12-31 | $601k | 24k | 25.27 |
More positions owned by Guggenheim Capital, LLC Managers
View all positions for Guggenheim Capital, LLC Managers